SMi Source Lesson Oncology: Head and Neck

  • SMi Source lesson Oncology: Head and Neck has the following microlearning topics

  • 1. Learning Objectives

    2. Introduction: Head and Neck Cancers

    3. Introduction: Treatment for Head and Neck Cancers

    4. Introduction

    5. Head and Neck Anatomy

    6. Head and Neck Anatomy

    7. Cellular Classification: Squamous Cell Carcinoma

    8. Cellular Classification: Nasopharyngeal Carcinoma

    9. Cellular Classification: Salivary Gland Cancers

    10. Cellular Classification: Malignant Salivary Gland Neoplasms

    11. Risk Factors: Tobacco

    12. Risk Factors: Alcohol and Pathogens

    13. Risk Factors: Pathogens HPV

    14. Risk Factors: Pathogens, UV Light Occupational and Radiation Exposures

    15. Risk Factors: Diet, Oral Hygiene and Inherited Conditions

    16. Mechanisms of Disease Development and Progression: Pathogenesis of HNSCC

    17. Anatomy and Pathophysiology

    18. Anatomy and Pathophysiology

    19. Mechanisms of Disease Development and Progression: Immune System Evasion

    20. Incidence

    21. Epidemiology

    22. Clinical Presentation: Signs and Symptoms

    23. Clinical Presentation: Physical Examination

    24. Clinical Presentation: Staging Investigations

    25. Staging

    26. Treatment Overview: Head and Neck Cancers

    27. Treatment Overview: Status and Goals

    28. Treatment Overview: Therapies and Treatment

    29. Treatment Overview: Additional Treatment and Surveillance

    30. Impact of Disease and Treatment

    31. Curative Surgery

    32. Radiation Therapy (RT): Treatment of HNSCC

    33. Radiation Therapy (RT): Radiation Fractionation, IMRT, Brachytherapy

    34. Radiation Therapy (RT): Complications

    35. Chemotherapy (CTx): Advantages and Recommendations

    36. Chemotherapy (CTx): Concurrent Chemoradiotherapy (CRT), Induction Chemotherapy (IC)

    37. Chemotherapy (CTx): Recurrent, Unresectable, and Metastatic Cancer Chemotherapy

    38. Chemotherapy (CTx): Toxicities of Treatment, HNSCC Chemotherapy Agents

    39. Palliative Therapy

    40. Salivary Gland Cancer

    41. HPV-Positive HNSCC

    42. Protocols

    43. NCCN Treatment Guidelines

    44. Overview: Investigational Strategies in the Treatment of Head and Neck Cancers

    45. Epidermal Growth Factor Receptor (EGFR)

    46. Tyrosine Kinase Inhibitors

    47. TGF Pathway

    48. VEGF

    49. c-Kit and HER-2, Carcinoembryonic Antigen (CEA) and Targeted Therapy Clinical Trials for HNSCC

    50. Vaccines for HNSCC

    51. Evolution of Head and Neck Cancer Treatment

    52. Radiotherapy Studies

    53. Postoperative Radiotherapy and Chemoradiotherapy

    54. Concurrent Chemoradiation Regimens: Standard of Care

    55. Concurrent Chemoradiation Regimens: Incidence of Acute Adverse Events

    56. Induction Chemotherapy: TAX 232 and TAX 324 Studies

    57. Induction Chemotherapy: VA Cooperative and RTOG 91-11 Studies

    58. Recurrent Unresectable/Metastatic HNSCC

    59. New Targeted Therapies: Molecular Therapies in HNSCC

    60. New Targeted Therapies: Targeted Therapies as Single Therapies

    61. Salivary Gland Cancer

    62. Conclusions: Head and Neck Cancer Epidemiology and Genetics

    63. Conclusions: Head and Neck Treatment